ריבסטיגמין טבע 4.5 מג
abic marketing ltd, israel - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine
ריבסטיגמין טבע 6 מג
abic marketing ltd, israel - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine
גאלאפולד 123 מג
truemed ltd, israel - migalastat as hydrochloride - קפסולה קשיחה - migalastat as hydrochloride 123 mg
igg avidity testing -citomegalovirus igg avidity eia well,rubella igg avidity eia well
איילקס ביוטק בע"מ - מומחה - ערכות תבחין אין ויטרו לבדיקת נוזלי גוף אדם לצורך איתור נוגדנים
טרובלט 50 מ"ג , טרובלט 100 מ"ג
glaxo smith kline (israel) ltd - retigabine 100 mg; retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
igg subclass or iga subclass kits
י.א אלמוג דיאגנוסטיקה וציוד רפואי בע"מ - צוות טכני - קביעת חסר חיסוני בחולים ע'י קביעת כמות ה-
טרובלט 50 מ"ג
glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 100 מ"ג
glaxo smith kline (israel) ltd - retigabine 100 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 300 מ"ג
glaxo smith kline (israel) ltd - retigabine 300 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.
טרובלט 400 מ"ג
glaxo smith kline (israel) ltd - retigabine 400 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.